AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vanglimpride 2mg/500mg/0.2mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Vanesha Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Vanglimpride 2mg/500mg/0.2mg Tablet ER

Diabetol-Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as anti-diabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. Diabetol-Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia and increased risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize its symptoms – sweating, dizziness, headache, trembling – and know how to treat it. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Vanglimpride 2mg/500mg/0.2mg Tablet ER

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Vanglimpride 2mg/500mg/0.2mg Tablet ER

Managing type 2 diabetes

Major Benefits of Vanglimpride 2mg/500mg/0.2mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Vanglimpride 2mg/500mg/0.2mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Vanglimpride 2mg/500mg/0.2mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Vanglimpride 2mg/500mg/0.2mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Vanglimpride 2mg/500mg/0.2mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Vanglimpride 2mg/500mg/0.2mg Tablet ER works:

Extended-release Vanglimpride tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Vanglimpride 2mg/500mg/0.2mg Tablet ER should not be taken together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Vanglimpride tablets (2mg/500mg/0.2mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vanglimpride tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Vanglimpride 2mg/500mg/0.2mg Extended-Release tablets in individuals with kidney impairment is likely inadvisable and should be forgone. Medical advice is recommended. Furthermore, its use is discouraged for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Individuals with liver impairment should use Vanglimpride 2mg/500mg/0.2mg Extended-Release tablets cautiously. Dosage modification of Vanglimpride 2mg/500mg/0.2mg Extended-Release tablets may be necessary. Physician consultation is advised. In patients experiencing mild to moderate liver disease, Vanglimpride 2mg/500mg/0.2mg Extended-Release tablets are typically initiated at a low dose; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Vanglimpride 2mg/500mg/0.2mg Tablet ER :

Should you forget to take a Vanglimpride 2mg/500mg/0.2mg Extended-Release tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vanglimpride 2mg/500mg/0.2mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vanglimpride 2mg/500mg/0.2mg Tablet ER

Vanglimpride ER tablets (2mg/500mg/0.2mg) combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Vanglimpride 2mg/500mg/0.2mg Extended-Release tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infection.
Vanglimpride 2mg/500mg/0.2mg Tablet ER is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Vanglimpride 2mg/500mg/0.2mg ER tablets with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vanglimpride 2mg/500mg/0.2mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly sealed container, following the storage instructions on the packaging. Dispose of any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Vanglimpride 2mg/500mg/0....
108
MRP 125
13% off